BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06284486-completion@plaintrial.com
DTSTAMP:20261110T225815Z
DTSTART;VALUE=DATE:20281230
SUMMARY:A Multi-Site Break Through Cancer Trial: Phase II Study Investigati
 ng Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of V
 enetoclax and Revumenib — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06284486
URL:https://plaintrial.com/trial/NCT06284486
END:VEVENT
END:VCALENDAR